N. Gassian

Most-cited papers

1. Activity and tolerability of maintenance avelumab immunotherapy after first line polychemotherapy including platinum in patients with locally advanced or metastatic squamous cell penile carcinoma: PULSE.

   N. Gassian, A. Frontczak, G. Mouillet, D. Vernerey +7 more

   2020Bulletin du Cancer12 citations Open access

   Semantic Scholar

   Save

2. [Systemic treatment of locally advanced or metastatic penile cancer].

   N. Gassian, A. Frontczak, A. El Kaddissi, F. Calcagno +8 more

   2020Bulletin du Cancer4 citations Open access

   Semantic Scholar

   Save

3. [DNA damage repair: An emerging strategy in metastatic prostate cancer].

   Y. Loriot, G. Meynard, E. Klajer, C. Bolognini +2 more

   2018Bulletin du Cancer4 citations

   Semantic Scholar

   Save

4. Evaluation of drug-drug interactions among patients with metastatic prostate cancer in routine care.

   N. Gassian, A. Clairet, M. Goujon, A. Frontczak +8 more

   2022Journal of Clinical Oncology1 citations

   Semantic Scholar

   Save

5. Concurrent diagnosis of oropharynx cancer and bone sarcoidosis mimicking metastasis.

   J. Razanamahery, M. Caubet, N. Gassian, C. Echalier +1 more

   2020Cancer Radiothérapie1 citations Open access

   Semantic Scholar

   Save

6. HERibuline: Eribulin mesylate and Trastuzumab in pretreated HER2-positive advanced breast cancer—A report of region’s practice.

   N. Gassian, S. Paget-Bailly, Oum El Kheir Djoumakh, L. Mansi +10 more

   2022Journal of Clinical Oncology0 citations

   Semantic Scholar

   Save

7. PULSE: A single arm trial assessing the activity and safety of avelumab immunotherapy maintenance among patients with locally advanced or metastatic squamous cell penile carcinoma (mSCPC)

   N. Gassian, G. Mouillet, D. Vernerey, O. Manseur +6 more

   2019Annals of Oncology0 citations Open access

   Semantic Scholar

   Save